Current Drugs with Potential for Treatment of COVID-19: A Literature Review.

CONCLUSION: All examined treatments, although potentiality effective against COVID-19, need either appropriate drug development or clinical trial to be suitable for clinical use. PMID: 32251618 [PubMed - as supplied by publisher]
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research

Related Links:

Publication date: Available online 25 May 2020Source: Journal of the American College of RadiologyAuthor(s): Sherry S. Wang, Marilyn A. Roubidoux
Source: Journal of the American College of Radiology - Category: Radiology Source Type: research
Publication date: Available online 25 May 2020Source: Academic RadiologyAuthor(s): Amel Amalou, Baris Turkbey, Sheng Xu, Evrim Turkbey, Peng An, Gianpaolo Carrafiello, Anna Maria Ierardi, Robert Suh, Hayet Amalou, Bradford J. Wood
Source: Academic Radiology - Category: Radiology Source Type: research
Authors: Tung-Chen Y PMID: 32446685 [PubMed - as supplied by publisher]
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
Authors: Pérez-Suárez B, Martínez-Menchón T, Cutillas-Marco E PMID: 32446684 [PubMed - as supplied by publisher]
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
Authors: López Castro J PMID: 32446683 [PubMed - as supplied by publisher]
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
AbstractSARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provides some examples collected from Asia, Europe, the Americas and Africa, ranging from essential services to meet human rights basic needs, extended generalist services developed to ensure continuity of care and supply of essential medicines to the development of differentiated extended responsibilities in emergency care. All examples were collected using a network of pharmacists from 27 countries, representing ...
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research
A light bulb went off when I saw a bumper sticker for sale that read “Always remember you’re unique, just like everyone else.” Yes, we are special. But are we more special than others? Many people flash a wry smile as they read my head-turning — if not head-scratching — bumper sticker. Attachment theory tells us that children need to feel welcomed, wanted, and loved. They need to feel special in the eyes of caregivers in order to develop a secure internal based. Even as adults, we want to feel special to our partner and close friends. But can our desire to be special become a liability? It&rs...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Happiness Mental Health and Wellness Psychology Self-Esteem Self-Help mutual authenticity Perfectionism self-worth Source Type: blogs
Publication date: Available online 24 May 2020Source: Journal of Minimally Invasive GynecologyAuthor(s):
Source: Journal of Minimally Invasive Gynecology - Category: OBGYN Source Type: research
Psychologists say anxiety and uncertainty prompt irrational decisions — like turning down a transplant when an organ becomes available.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Transplants Emergency Medical Treatment Coronavirus (2019-nCoV) Liver Fear (Emotion) Anxiety and Stress Cancer Heart your-feed-science your-feed-healthcare Source Type: news
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: China Health | Clinical Trials | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Ebola | Ebola Vaccine | Laboratory Medicine | Malaria | Malaria Vaccine | MERS | Middle East Health | Respiratory Medicine | SARS | Science | Study | Vaccines | Veterinary Vaccinations